Atherogenic index of plasma in COVID-19 infection

• DOI: 10.5281/zenodo.7855675
• Publication Date: 2023-04-24
• Authors: Dikker, Okan; İncirkuş, Fatih; Ak, Kenan; Arabacı, Çiğdem; Dağ, Hüseyin
• Keywords: 03 medical and health sciences; 0302 clinical medicine; Atherogenic index of plasma, Cardiac risk, COVID-19; 3. Good health

The atherogenic index of plasma (AIP) is calculated as the logarithmic conversion of the triglyceride to high density lipoprotein-cholesterol ratio [log10(Triglyceride/HDL-cholesterol)]. AIP values of 0.21 are considered higher risk. AIP produced by triglycerides and HDL-cholesterol, avoiding the inconsistent assessment of different lipid components and simplifies task of a marker in clinical application. It has been reported that AIP value is an important predictor for cardiovascular diseases and atherosclerosis. COVID-19 is a viral infection that started in 2019 and quickly caused a pandemic. And it continues to cause death, especially in people with pre-existing comorbidities. COVID-19 infection is associated with lipid levels and cardiovascular disease. Studies have shown that AIP levels are high in COVID-19 patients. In addition, studies have found that high AIP values are associated with prolonged hospital stay, poor prognosis, and increased disease severity. Reporting of AIP